Ropes & Gray and Latham & Watkins are among several Am Law 100 firms landing lead roles this week on a quartet of deals in the pharmaceutical and biosciences sector.
Pepper Hamilton, Shearman & Sterling, Sidley Austin, and Sullivan & Cromwell have also picked up work from the transactions, which include URL Pharma’s purchase by Takeda Pharmaceuticals; the sale of Becton Dickinson’s biosciences unit to Corning; Genstar Capital’s acquisition of eResearch Technology (ERT); and KAI Pharmaceuticals’s sale to Amgen.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
